MIRAGRON S 25/5: Uses, Benefits, Dosage, Price & Mechanism of Action....

MIRAGRON S 25/5 

Mirabegron (ER) (25mg) and Solifenacin succinate (5mg)

MIRAGRON S 25/5 combination of Mirabegron (ER) (25mg) and Solifenacin Succinate (5mg) are two potent medications often prescribed together for the treatment of overactive bladder (OAB). In this article, we explore the combined benefits and therapeutic synergy of this dual-action approach.

Mirabegron (ER) (25mg):

• Selective Beta-3 Adrenergic Agonist: Mirabegron (ER) (25mg) acts as a selective beta-3 adrenergic receptor agonist, relaxing the detrusor muscle in the bladder. This action increases bladder capacity and reduces the frequency and urgency of urination associated with OAB.

• Extended-Release Formulation: The extended-release formulation of Mirabegron (ER) (25mg) ensures sustained plasma levels, allowing for once-daily dosing and continuous bladder relaxation throughout the day.

Solifenacin Succinate (5mg):

• Muscarinic Receptor Antagonist: Solifenacin Succinate (5mg) is a muscarinic receptor antagonist that inhibits bladder contractions by blocking the action of acetylcholine. This leads to reduced urinary urgency and frequency in patients with OAB.

• Bladder Selectivity: Solifenacin Succinate (5mg) exhibits high selectivity for muscarinic receptors in the bladder, minimizing the risk of systemic side effects commonly associated with anticholinergic medications.

MIRAGRON S 25/5: The Ultimate OAB Solution

• Dual-Action Mechanism: MIRAGRON S 25/5 combines the complementary mechanisms of Mirabegron (ER) (25mg) and Solifenacin Succinate (5mg), providing a comprehensive approach to OAB management. Together, they target both bladder muscle relaxation and inhibition of bladder contractions, resulting in improved symptom control.

• Enhanced Symptom Relief: By addressing multiple aspects of OAB pathophysiology, MIRAGRON S 25/5 offers enhanced symptom relief, including reduced urinary urgency, frequency, and urge incontinence episodes. Patients experience improved bladder control and a better quality of life.

Patient-Centric Benefits:

• Tailored Treatment: MIRAGRON S 25/5 allows healthcare providers to tailor treatment to the individual needs of patients with OAB, optimizing treatment outcomes and improving patient satisfaction.

• Convenience and Compliance: The once-daily dosing regimen of MIRAGRON S 25/5 enhances treatment adherence and compliance, ensuring consistent symptom relief and long-term bladder health for patients.

Conclusion:

In conclusion, the combination of Mirabegron (ER) (25mg) and Solifenacin Succinate (5mg) in the form of MIRAGRON S 25/5 offers a comprehensive and effective solution for the management of overactive bladder. With its synergistic mechanisms and patient-centric benefits, this combination therapy provides improved symptom relief and enhanced bladder control for patients with OAB.Steris Healthcare Pvt Ltd, founded by a group of expert professionals in the pharmaceutical industry in February 2018, operates as Sterispharma. This company, which is based in Navi Mumbai, holds certifications from WHO, GMP, and ISO. Its commitment is to provide high-quality drugs at affordable prices to its customers throughout India, following the rigorous guidelines set by the WHO. Steris offers the convenience of an online pharmacy where customers can easily buy medicines and enjoy the benefit of home delivery. At Steris, the mission is to supply a wide array of healthcare products designed to meet the varied needs of the medical community. Whether it is advanced treatments, medications for rare conditions, or basic health necessities, Sterispharma strives to serve the healthcare industry’s broad demands. The extensive product lineup from Steris includes treatments for various health areas such as Cardiology, Asthma, Respiratory issues, Nasal conditions, Diabetes, Endocrinology, Gastroenterology, Orthopedics, Anti-infectives/antibiotics, General Medicine, Urology, Neurology, Nephrology, Oncology, Gynecology, Pediatrics, Dental care, and Dermatology.

For further information: 

EMAIL:  info@sterispharma.com  / contact@sterispharma.com   

CALL/WHATSAPP: 7877551268, 7849827488

BUY NOW